MUC1 is a cell membrane glycoprotein that is also overexpressed in NSCLC and has been implicated in the carcinogenesis of premalignant lung lesions; thus, MUC1 has been used as a target for cancer vaccine strategies [8]. This evidence concerns the gene MUC1 and non-small cell lung carcinoma.